No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
224 |
4. Check minimum number of eventsNone |
224 |
5. Include endpointsNone |
224 |
6. Filter based on genotype QC (FinnGen only) |
224 |
Control definitions (FinnGen only)
- Control exclude
- H8_OTHEREAR
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H92
- Name in latin
- Otorrhagia
Similar endpoints
↥List of similar endpoints to
Otorrhagia
based on the number of shared cases.
Similar with more cases:
- Other disorders of ear
- Diseases of the ear and mastoid process
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1851 | 828 | 1014 |
| Only index persons | 1598 | 720 | 878 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.02 | 0.03 |
| Only index persons | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 56.80 | 63.46 | 51.22 |
| Only index persons | 59.29 | 66.15 | 53.66 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 224 | 103 | 121 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.05 |
| Median age at first event (years) | 63.43 | 63.89 | 63.04 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 200
- Matched controls
- 1999
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H92.2
ICD-10 Finland
Otorrhagia
+∞
285.1
200
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
64.3
32.6
37
7
UDC00
NOMESCO Finland
Ear microscopy
9.8
18.8
39
48
DFF00
NOMESCO Finland
Pure tone audiometry
11.9
15.3
28
27
H92.0
ICD-10 Finland
Otalgia
9.2
11.7
24
29
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.5
11.6
43
114
I48
ICD-10 Finland
Atrial fibrillation and flutter
3.2
11.2
70
287
H05
ICPC
Bleeding ear
63.4
10.7
12
*
R04.0
ICD-10 Finland
Epistaxis
4.9
9.2
30
69
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
3.0
9.1
60
249
H91.9
ICD-10 Finland
Hearing loss, unspecified
13.6
8.5
14
11
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
8.5
71
340
R4110
NOMESCO Finland
Physiotherapy
2.7
8.4
71
343
ZXA05
NOMESCO Finland
Left side
2.7
8.4
66
304
AA1AD
NOMESCO Finland
CT of head and brain
2.8
8.4
61
267
ZXA10
NOMESCO Finland
Bilateral
3.1
8.4
50
194
Z3231
NOMESCO Finland
Registered nurse
2.6
8.3
76
382
B01AA03
ATC
warfarin; systemic
2.8
8.3
63
282
N02BE01
ATC
paracetamol; systemic, rectal
3.1
8.2
173
1353
WX110
NOMESCO Finland
Local anesthesy
2.5
8.1
144
1016
H65.3
ICD-10 Finland
Chronic mucoid otitis media
8.3
8.1
17
22
C03CA01
ATC
furosemide; systemic
2.4
7.5
77
408
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.3
7.5
94
549
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
8.9
7.5
15
18
N02AX02
ATC
tramadol; systemic, rectal
2.3
7.4
96
569
H02AB06
ATC
prednisolone; systemic
2.3
7.3
100
610
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
4.0
7.0
28
79
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
7.0
69
355
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
7.0
52
229
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
6.8
96
586
L17
ICPC
Foot/toe symptom/complaint
2.5
6.8
60
292
C07AB07
ATC
bisoprolol; oral
2.2
6.7
104
661
Z3226
NOMESCO Finland
Physiotherapist
2.6
6.5
51
229
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
6.5
36
132
D11
ICPC
Diarrhoea
3.6
6.4
28
86
Z3229
NOMESCO Finland
Other healthcare associate professional
3.8
6.4
26
75
S01.3
ICD-10 Finland
Open wound of ear
18.7
6.3
9
5
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
6.3
84
493
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
+∞
6.3
6
*
I50.9
ICD-10 Finland
Heart failure, unspecified
2.8
6.2
41
166
Z97.4
ICD-10 Finland
Presence of external hearing-aid
13.1
6.1
10
8
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.1
6.1
18
38
TFP20
NOMESCO Finland
Cardiodefibrillation
3.6
6.1
26
79
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022217) INR in Platelet poor plasma by Coagulation assay
63
236
3.32
13.46
36.3
23.3
inr
1.4
1.3
—
5
29
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
87
442
2.58
10.25
2.7
2.2
mg/l
2.7
3.2
1.16
80
381
(3000991) Gas panel - Venous blood
49
188
3.06
9.83
12.0
9.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
117
715
2.33
8.85
16.0
9.3
inr
1.4
1.3
0.54
28
210
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
127
811
2.31
8.57
13.0
6.8
mmol/l
1.2
1.2
0.51
118
744
(3036489) Thrombin time
27
77
3.85
8.55
3.1
2.6
s
22.7
22.0
0.26
22
71
(3024561) Albumin [Mass/volume] in Serum or Plasma
123
786
2.25
8.15
7.8
5.1
g/l
35.3
35.5
0.14
115
749
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
56
4.25
8.09
5.5
2.3
u/ml
0.3
0.3
0.40
16
26
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
95
553
2.25
7.83
5.0
3.0
ng/l
2509.0
1578.7
0.68
83
465
(3023520) Reticulocytes [#/volume] in Blood
41
161
2.89
7.81
2.5
2.8
e9/l
71.0
68.2
0.17
31
117
(3042936) Bacteria identified in Isolate by Culture
56
262
2.52
7.56
2.4
1.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
137
936
2.19
7.43
7.8
6.0
e9/l
0.2
0.2
0.29
117
805
(3027945) Reticulocytes/100 erythrocytes in Blood
51
230
2.58
7.42
2.7
2.7
%
1.9
1.7
0.62
45
209
(3006315) Basophils [#/volume] in Blood
134
908
2.18
7.42
7.4
5.8
e9/l
0.0
0.0
0.11
113
771
(3001604) Monocytes [#/volume] in Blood
133
903
2.16
7.27
7.1
5.8
e9/l
0.6
0.6
1.69
113
763
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
91
534
2.19
7.24
2.3
2.1
u/l
178.9
487.3
0.99
84
505
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
61
303
2.39
7.21
2.4
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
132
896
2.15
7.19
14.4
7.4
mmol/l
1.2
1.2
0.73
116
766
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
108
681
2.13
7.11
2.4
2.0
pmol/l
91.7
90.9
0.06
60
339
(3019198) Lymphocytes [#/volume] in Blood
135
933
2.12
6.91
7.5
5.9
e9/l
1.9
2.1
0.28
113
811
(3019069) Monocytes/100 leukocytes in Blood
126
859
2.07
6.57
7.5
6.2
%
9.1
8.6
0.86
119
809
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
65
345
2.25
6.52
5.5
3.5
ng/l
151.4
299.5
0.60
53
284
(3001122) Ferritin [Mass/volume] in Serum or Plasma
112
734
2.05
6.48
4.5
2.7
ug/l
193.6
126.7
0.84
106
678
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
106
682
2.05
6.44
5.9
3.9
ng/l
27.0
47.6
1.60
77
498
(3003458) Phosphate [Moles/volume] in Serum or Plasma
52
252
2.39
6.43
12.6
6.7
mmol/l
1.2
1.1
0.43
47
230
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
33
128
2.85
6.39
5.2
2.9
ml/min/173m2
47.1
67.2
2.06
15
57
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
48
225
2.44
6.39
2.3
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
146
1065
2.07
6.16
12.0
9.3
e9/l
4.1
4.2
0.18
124
915
(42870588) Differential panel, method unspecified - Blood
98
622
2.02
6.10
7.6
5.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
124
856
2.00
6.08
7.4
5.8
%
2.6
2.8
0.33
117
801
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
48
230
2.38
6.07
2.4
1.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
121
831
1.99
5.99
7.4
5.9
%
0.6
0.7
0.33
114
775
(3023368) Bacteria identified in Blood by Culture
88
541
2.03
5.96
5.1
4.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
125
873
1.98
5.85
7.3
5.8
%
56.7
57.8
0.34
116
821
(3013826) Glucose [Moles/volume] in Serum or Plasma
144
1060
2.00
5.74
9.9
5.5
mmol/l
6.9
6.7
0.45
137
982
(3007853) Bacteria identified in Skin by Aerobe culture
43
201
2.41
5.73
2.0
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
125
885
1.93
5.49
7.5
6.0
%
27.1
27.4
0.08
117
829
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
87
547
1.97
5.43
3.3
2.4
u/l
57.7
56.2
0.18
81
509
(3011397) Hemoglobin [Presence] in Urine by Test strip
70
411
2.02
5.28
3.8
4.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
80
494
1.96
5.23
10.4
6.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
29
117
2.70
5.21
2.1
1.6
—
—
—
0
0
(3012544) pH of Venous blood
44
219
2.26
5.06
10.0
6.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
75
459
1.95
4.99
3.7
2.8
umol/l
363.4
8188.0
2.36
66
392
(3021960) Folate [Moles/volume] in Serum or Plasma
71
427
1.97
4.97
1.8
1.6
nmol/l
20.7
20.8
0.02
64
358
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
67
399
1.97
4.81
2.9
1.8
mg/l
1.2
1.3
0.26
51
308
(40768797) Stomach Pathology biopsy report
43
217
2.21
4.77
1.3
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
172
1390
2.02
4.75
10.4
7.3
u/l
82.3
81.7
0.07
166
1307
(3044640) Blood type and Crossmatch panel - Blood
86
560
1.87
4.70
3.9
2.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
68
413
1.93
4.58
3.7
2.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
86
564
1.85
4.57
8.3
3.7
ph
7.4
7.4
—
9
110
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
22
4.71
4.35
1.7
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
112
805
1.78
4.34
5.3
4.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
42
219
2.13
4.29
11.8
8.1
mmol/l
1.3
1.0
0.27
35
178
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
35
171
2.24
4.19
2.5
2.5
u/l
27.5
37.1
1.18
29
141
(3044889) 12 lead EKG panel
155
1234
1.83
4.18
4.6
3.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
101
712
1.76
4.13
3.2
2.4
nmol/l
78.4
76.5
0.26
88
628
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
42
3.49
4.11
2.0
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
99
696
1.76
4.07
4.9
3.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
19
70
2.87
4.03
1.3
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
56
334
1.90
3.93
4.2
2.9
e6/l
1.8
2.3
0.30
35
171
(3014576) Chloride [Moles/volume] in Serum or Plasma
46
257
1.99
3.89
13.5
7.3
mmol/l
103.5
104.0
0.33
46
249
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
160
1300
1.81
3.87
4.7
3.8
pmol/l
15.0
14.9
0.20
150
1161
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
5
12.27
3.78
2.7
4.6
nmol/l
369.0
56.6
—
6
5
(36660697) Celiac disease serology panel - Serum
26
117
2.38
3.75
1.2
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
53
315
1.89
3.74
1.9
1.8
nmol/l
1106.1
1200.7
0.34
41
241
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
145
1154
1.73
3.68
4.1
3.1
u/l
58.0
46.3
0.86
136
1078
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
202
1787
2.33
3.62
26.6
14.8
mg/l
25.3
26.0
0.10
171
1410
(3009508) Creatinine [Moles/volume] in Urine
77
519
1.74
3.59
4.5
3.3
mmol/l
7.3
7.7
0.38
66
434
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
187
1610
1.98
3.58
4.6
3.9
mmol/l
1.2
1.3
0.59
169
1470
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
31
3.68
3.53
1.5
1.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
6
10.23
3.51
2.8
1.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
184
1580
1.92
3.49
5.6
4.6
mu/l
2.0
1.9
0.23
174
1433
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
76
2.64
3.48
2.4
2.5
g/l
6.5
7.5
1.92
12
56
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
76
2.64
3.48
2.4
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
76
2.64
3.48
2.4
2.5
g/l
3.9
3.7
0.11
12
53
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
57
356
1.81
3.42
3.4
2.8
e6/l
1.6
0.9
0.57
35
190
(3014051) Protein [Presence] in Urine by Test strip
12
37
3.37
3.39
3.8
2.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
12
37
3.37
3.39
2.9
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
65
2.75
3.39
3.1
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
28
137
2.19
3.34
1.4
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
38
3.28
3.26
2.9
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
80
559
1.67
3.21
4.1
3.2
e6/l
0.2
0.4
1.81
58
413
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
58
372
1.75
3.17
1.5
1.3
u/ml
4.1
1.3
0.48
12
104
(3003338) MCHC [Mass/volume]
177
1520
1.78
3.11
34.7
18.9
g/l
330.5
333.0
2.80
177
1512
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
87
2.43
3.11
16.5
11.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
193
1703
1.96
3.09
5.8
4.9
mmol/l
2.4
2.7
4.91
176
1558
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
189
1657
1.90
3.08
4.9
4.4
mmol/l
6.0
6.0
0.04
175
1504
(3013707) Erythrocyte sedimentation rate by Westergren method
156
1298
1.66
3.05
5.0
4.1
mm/h
13.2
11.9
0.46
145
1191
(3002582) Erythrocytes [#/volume] in Urine
86
619
1.63
3.05
4.9
3.2
e6/l
81.6
45.6
0.26
66
472
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
70
2.55
2.96
2.4
2.6
g/l
3.0
3.1
0.39
12
55
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
17
4.84
2.94
2.0
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
207
1881
2.32
2.94
14.9
10.2
u/l
27.2
25.7
0.42
202
1812
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
134
1080
1.60
2.93
3.3
3.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
85
615
1.62
2.93
4.2
3.4
mmol/l
2.3
2.4
0.02
75
556
(40768804) Tissue Pathology biopsy report
89
653
1.60
2.88
2.3
2.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
25
125
2.13
2.84
8.4
4.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
69
477
1.65
2.84
3.9
3.3
mg/l
76.8
70.1
0.05
46
329
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
188
1659
1.83
2.82
5.2
4.3
mmol/l
1.3
1.4
2.65
172
1519
(40761535) Cells panel - Urine sediment
27
141
2.04
2.74
3.9
4.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
11
37
3.07
2.73
12.0
6.0
%
71.8
69.7
0.12
11
37
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
188
1664
1.81
2.72
5.3
4.4
mmol/l
4.1
4.6
8.15
173
1535
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
5
7
7.27
2.56
1.2
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
71
507
1.59
2.53
4.7
4.0
mg/mmol
16.4
11.5
0.20
47
326
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
53
352
1.66
2.52
3.0
3.2
mmol/l
2.5
2.5
0.17
48
316
(3037467) Urinalysis macro (dipstick) panel - Urine
143
1193
1.55
2.51
6.1
4.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
11
39
2.91
2.51
2.4
1.7
u/ml
180.5
298.9
—
6
19
(3003327) Ova and parasites identified in Stool by Light microscopy
14
57
2.55
2.50
1.7
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
51
2.64
2.49
12.8
7.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
18
83
2.27
2.48
2.7
2.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
73
527
1.57
2.47
4.0
3.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
24
125
2.03
2.47
3.0
2.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
52
2.59
2.40
2.0
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
202
1848
1.95
2.34
24.3
13.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
41
2.77
2.31
2.4
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
34
204
1.79
2.31
2.3
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
212
1975
2.37
2.31
38.3
21.1
e12/l
4.4
4.5
3.16
207
1901
(3037522) Nuclear Ab [Titer] in Serum
36
220
1.76
2.30
1.4
1.4
titre
354.3
517.9
—
7
58
(36304419) Bacteria [Presence] in Urine
74
545
1.53
2.27
4.4
3.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
60
2.42
2.27
2.1
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
122
1.99
2.26
2.6
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
32
190
1.80
2.25
2.5
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
36
2.86
2.23
1.6
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
90
696
1.49
2.18
6.3
3.7
e6/l
36.2
52.2
0.51
67
500
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
14
4.37
2.16
2.2
2.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
43
2.64
2.13
2.3
1.2
—
—
—
0
0
(4306422)
8
25
3.28
2.11
1.3
1.3
—
—
—
0
0
(44790047)
9
31
2.98
2.09
1.6
1.8
—
—
—
0
0
(44790048)
9
31
2.98
2.09
1.6
1.8
—
—
—
0
0
(44790049)
9
31
2.98
2.09
1.6
1.8
—
—
—
0
0
(44806118)
9
31
2.98
2.09
1.6
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
107
862
1.46
2.08
11.8
9.5
e9/l
0.0
0.0
0.47
87
690
(3021879) Hepatitis B virus core Ab [Presence] in Serum
22
119
1.94
2.06
1.6
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
107
864
1.46
2.05
4.4
3.9
estimate
0.0
0.0
0.00
13
168
(3009542) Hematocrit [Volume Fraction] of Blood
180
1613
1.59
2.03
30.2
15.9
%
38.5
39.8
1.01
133
1193
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
178
1592
1.58
2.01
7.2
5.7
mmol/mol
40.4
40.1
0.13
166
1484
(3020891) Body temperature
16
78
2.13
1.96
10.9
4.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
27
3.03
1.95
1.0
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
33
2.80
1.95
1.4
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
16
3.82
1.95
1.2
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
16
3.82
1.95
1.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
16
3.82
1.95
1.2
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
23
129
1.87
1.94
11.0
5.2
mmol/l
24.2
24.1
0.05
23
117
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
22
3.25
1.89
1.1
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
171
1524
1.52
1.88
32.2
18.0
%
14.0
13.7
1.87
166
1496
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
17
3.60
1.85
1.2
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
44
301
1.57
1.85
2.4
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
18
3.39
1.76
2.0
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
57
419
1.48
1.72
3.5
2.5
e6/l
5.2
4.5
0.27
44
377
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
13
3.91
1.72
1.0
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
13
3.91
1.72
1.6
2.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
107
884
1.40
1.72
4.7
4.0
estimate
0.0
0.0
0.00
14
168
(3026782) Osmolality of Urine
55
405
1.47
1.65
4.4
2.6
mosm/kgh2o
508.8
563.7
1.01
43
348
(3021601) Nitrite [Presence] in Urine by Test strip
105
871
1.39
1.62
6.3
5.3
estimate
0.0
0.0
0.00
14
170
(3007164) IgA [Mass/volume] in Serum or Plasma
50
364
1.48
1.58
1.6
1.4
g/l
2.6
2.4
0.22
25
229
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
179
1632
1.48
1.56
23.6
13.7
ml/min/173m2
76.5
80.1
1.00
152
1336
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
48
348
1.48
1.55
1.7
1.9
pmol/l
176316306.6
444.4
0.49
38
301
(3026389) Candida sp identified in Specimen by Organism specific culture
5
15
3.38
1.53
1.2
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
15
3.38
1.53
1.8
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
27
2.64
1.52
1.3
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
58
2.13
1.52
2.2
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
58
2.13
1.52
1.2
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
32
213
1.59
1.51
1.3
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
59
2.09
1.46
2.5
2.0
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
5
16
3.17
1.44
1.0
1.4
mg/l
6.4
3.7
—
5
16
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
12
60
2.06
1.41
2.6
2.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
46
607
0.70
1.39
3.2
2.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
148
0.46
1.37
1.3
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
23
2.65
1.37
1.5
3.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
43
2.14
1.32
5.7
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
12
62
1.99
1.30
1.1
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
10
48
2.13
1.29
5.5
2.9
—
1.3
—
0
5
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
55
2.05
1.29
1.5
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
24
155
1.61
1.29
4.6
4.8
%
0.0
0.1
—
8
45
(3000330) Specific gravity of Urine by Test strip
17
100
1.76
1.27
4.8
3.8
—
—
—
0
0
(3000492) Spirometry study
24
156
1.60
1.26
1.7
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
33
232
1.50
1.24
2.5
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
18
109
1.71
1.23
5.4
7.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
5
19
2.67
1.22
1.2
2.3
—
597.6
—
0
8
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
19
2.67
1.22
1.0
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
19
2.67
1.22
1.2
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
19
2.67
1.22
3.0
2.7
nmol/l
4.5
12.1
—
5
19
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
19
2.67
1.22
1.0
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
25
166
1.57
1.21
4.6
4.7
%
0.8
0.7
—
8
53
(3002179) Metamyelocytes/100 leukocytes in Blood
23
150
1.59
1.20
3.5
4.5
%
0.2
0.5
—
5
35
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
80
661
1.33
1.20
4.2
4.7
ug/l
2.0
2.6
0.49
71
585
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
38
2.15
1.19
1.1
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
33
0.00
1.17
0.0
1.1
—
0.6
—
0
26
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
34
0.00
1.17
0.0
1.1
—
7.7
—
0
28
(3034770) Mitochondria Ab [Titer] in Serum
8
39
2.09
1.16
1.6
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
39
2.09
1.16
1.0
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
20
2.53
1.15
1.4
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
20
2.53
1.15
1.4
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
20
2.53
1.15
1.4
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
20
2.53
1.15
1.4
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
20
2.53
1.15
1.4
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
20
2.53
1.15
2.4
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
20
2.53
1.15
1.4
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
52
407
1.36
1.10
4.8
5.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
32
2.22
1.09
6.0
3.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
32
2.22
1.09
1.9
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
21
138
1.58
1.07
3.3
2.4
g/l
10.8
9.7
0.41
21
125
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
18
114
1.63
1.06
2.2
2.3
—
6.8
—
0
6
(4268621)
5
22
2.30
1.04
4.6
2.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
22
2.30
1.04
6.6
8.8
%
11.5
11.9
—
5
22
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
134
0.51
1.02
1.0
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
21
140
1.55
1.02
5.3
7.4
mmol/l
0.5
1.5
0.90
12
111
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
35
2.03
1.01
2.9
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
12
69
1.78
0.98
9.9
2.8
mmol/l
3.9
4.0
0.34
12
62
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
23
2.20
0.98
1.2
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
23
2.20
0.98
1.2
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
0
30
0.00
0.98
0.0
4.4
—
6.4
—
0
24
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
9
50
1.83
0.98
1.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
27
2.25
0.94
1.3
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
28
2.17
0.92
6.2
2.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
11
63
1.78
0.92
4.3
3.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
30
2.03
0.87
6.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
44
1.85
0.87
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
44
1.85
0.87
1.6
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
46
1.77
0.83
5.0
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
8
47
1.73
0.81
1.1
1.2
—
3.9
—
0
5
(3019225) pH of Specimen
19
131
1.49
0.81
4.7
4.3
—
—
—
0
0
(4034850)
10
58
1.76
0.81
10.1
11.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
58
483
1.27
0.80
1.3
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
24
0.00
0.79
0.0
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
21
150
1.44
0.76
5.3
4.8
%
0.0
0.0
—
6
40
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
28
0.00
0.76
0.0
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
27
203
1.38
0.75
13.6
7.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
55
1.66
0.74
1.6
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
7
40
1.77
0.72
1.1
1.3
—
7.0
—
0
5
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
26
1.94
0.71
2.2
3.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
26
1.94
0.71
1.0
1.8
ug/l
19.4
20.6
—
5
26
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
26
1.94
0.71
1.4
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
69
1.62
0.69
3.3
2.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
29
225
1.33
0.67
2.3
2.5
ug/g
125.3
115.9
0.07
22
178
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
43
1.65
0.67
1.6
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
28
1.80
0.66
1.4
1.1
—
—
—
0
0
(3013512) EKG study
58
496
1.23
0.64
7.4
3.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
16
115
1.42
0.58
1.4
1.6
g/l
1.2
1.1
0.29
16
106
(3016879) Cocaine [Presence] in Urine
8
54
1.50
0.58
5.3
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
60
523
1.20
0.55
3.9
4.2
%
25.2
21.7
0.60
27
249
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
38
1.59
0.54
1.0
1.2
—
14.9
—
0
7
(3005322) IgE [Units/volume] in Serum or Plasma
13
91
1.45
0.54
1.1
1.2
u/ml
148.0
432.9
0.53
13
85
(3017732) Neutrophils [#/volume] in Blood
16
117
1.40
0.54
3.8
2.7
e9/l
4.8
4.0
0.37
11
95
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
39
1.55
0.53
1.8
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
18
135
1.36
0.53
4.2
2.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
74
666
1.17
0.47
4.4
4.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
54
476
1.18
0.44
4.5
4.2
estimate
0.0
0.0
0.00
14
162
(3000764) Benzodiazepines [Presence] in Urine
8
58
1.39
0.42
5.3
1.3
—
—
—
0
0
(4010399)
17
132
1.31
0.41
1.6
1.5
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
15
0.00
0.41
0.0
1.0
—
7.8
—
0
15
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
17
0.00
0.41
0.0
2.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.1
—
1.4
—
0
9
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
60
1.35
0.40
5.3
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
60
1.35
0.40
5.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
60
1.35
0.40
5.3
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
160
1.27
0.40
1.8
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
35
1.44
0.39
1.4
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
19
0.00
0.39
0.0
4.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
15
116
1.31
0.38
1.3
1.1
iu/ml
179.1
139.2
—
7
43
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
24
199
1.23
0.37
1.7
1.4
—
—
—
0
0
(4035726)
19
153
1.26
0.37
1.4
1.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
9
71
1.28
0.36
1.4
1.7
—
192.0
—
0
5
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
102
1.29
0.30
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
20
168
1.21
0.28
2.1
2.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
12
147
0.81
0.24
6.0
3.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
41
1.22
0.22
1.6
2.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
29
259
1.14
0.21
1.5
1.3
u/ml
1.6
15.6
1.90
12
110
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
11
0.00
0.21
0.0
1.0
—
170.9
—
0
11
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
11
89
1.25
0.21
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.4
—
4.3
—
0
6
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
12
0.00
0.21
0.0
1.8
—
13.5
—
0
12
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
14
0.00
0.20
0.0
1.0
—
3.1
—
0
14
(3017569) Oxygen content in Arterial blood
0
14
0.00
0.20
0.0
6.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
52
1.16
0.19
1.3
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
59
1.19
0.18
1.6
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
70
1.15
0.16
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
70
1.15
0.16
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
70
1.15
0.16
1.3
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
72
1.12
0.16
1.0
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
13
112
1.17
0.14
7.1
2.6
e6/l
0.2
0.1
0.37
13
105
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
98
0.81
0.14
1.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
46
487
0.93
0.13
4.3
3.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
95
1.17
0.12
1.3
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
28
300
0.92
0.10
1.4
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
45
1.11
0.10
1.6
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
58
1.04
0.08
1.2
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
60
0.83
0.08
1.6
2.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
83
0.84
0.07
1.6
2.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
17
159
1.07
0.05
2.1
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
20
190
1.06
0.04
4.9
4.1
%
34.8
31.3
0.71
15
118
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
159
0.94
0.03
1.3
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
11
102
1.08
0.03
1.3
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
39
399
0.97
0.02
2.5
2.8
ug/l
0.7
0.8
0.66
31
258
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
27
278
0.97
0.02
1.4
1.3
iu/ml
101.3
31.0
—
8
104
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
187
0.96
0.01
1.9
3.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
20
195
1.03
0.00
1.3
1.3
—
—
—
0
0
(1002224) Polysomnography panel
7
72
0.97
0.00
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
66
0.91
0.00
1.2
1.9
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
12.4
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
58
0.86
0.00
1.8
1.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
6.6
—
0
5
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.3
—
120.2
—
0
7
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.9
—
0.8
—
0
7
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.1
—
9.4
—
0
7
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
115.7
—
0
8
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
6.1
—
0
5
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
6.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
18.7
—
1.2
—
0
7
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
16.4
—
1.2
—
0
5
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
7
0.00
0.00
0.0
2.3
—
2406.4
—
0
7
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
62
0.97
0.00
5.5
4.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
14
140
1.00
0.00
2.1
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_OTORRHAGIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_OTORRHAGIA | 1.65 [1.23, 2.22] | 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.45 |
During the follow-up period (1.1.1998 — 31.12.2019), 153 out of 677 females with H8_OTORRHAGIA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_OTORRHAGIA | 2.165 [1.52, 3.07] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.012 |
During the follow-up period (1.1.1998 — 31.12.2019), 185 out of 847 males with H8_OTORRHAGIA died.
Mortality risk
Mortality risk for people of age
years, who have H8_OTORRHAGIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.191% | 0.416% |
| 5 | 0.975% | 2.488% |
| 10 | 2.277% | 5.739% |
| 15 | 4.61% | 10.897% |
| 20 | 8.497% | 17.972% |
Relationships between endpoints
↥Index endpoint: H8_OTORRHAGIA – Otorrhagia
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data